Marina Udier
Director/Board Member at CELYAD ONCOLOGY SA
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michel Lussier | M | 67 | 17 years | |
| Elisa Scarselli | F | - |
Nouscom Srl
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 17 years |
| John McDonald | M | 63 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| 6 years |
| Guido Magni | M | 70 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| - |
| Hilde Windels | F | 59 | 6 years | |
| Joachim Rothe | M | - |
Nouscom Srl
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | - |
| Genghis Lloyd-Harris | M | 67 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| - |
| Göran Albert Ando | M | 75 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| 4 years |
| Cinzia Traboni | M | - |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 17 years |
| Scott Rocklage | M | 69 |
Nouscom Srl
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | - |
| Jean-Paul Prieels | M | 78 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| - |
| Richard Davis | M | 51 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 4 years |
| Dominic Piscitelli | M | 50 | 4 years | |
| David Georges | M | - | 5 years | |
| Eytan Breman | M | - | 9 years | |
| Ami Patel Shah | F | - | 3 years | |
| Sage Mandel | F | - | - | |
| Richard Davis | M | 66 |
Nouscom Srl
| - |
| Vincent Brichard | M | - |
Nouscom Srl
| - |
| Jonathan M. James | M | - | - | |
| J. Christopher LiPuma | M | 53 | 2 years | |
| Serge Goblet | M | - | 16 years | |
| An Phan | F | 49 | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Georges Rawadi | M | - | 5 years | |
| Riccardo Cortese | M | 80 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 10 years |
| Christian Homsy | M | 65 | 12 years | |
| Patrick Jeanmart | M | 51 | 11 years | |
| William Wijns | M | - | 9 years | |
| Filippo Petti | M | 52 | 4 years | |
| Sara Zelkovic | F | - | - | |
| Peter de Waele | M | 67 | 7 years | |
| Frederic Lehmann | M | 60 | 7 years | |
| Hanspeter Spek | M | 72 | - | |
| Margo Roberts | M | 69 | 2 years | |
| Jean-Marc Heynderickx | M | 66 | 2 years | |
| Debasish Francois Roychowdhury | M | 63 | - | |
| Dieter Hauwaerts | M | - | 2 years | |
| Chris de Jonghe | M | - | 4 years | |
| Maria Koehler | M | 67 | - | |
| Alfredo Nicosia | M | - |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 12 years |
| Stephen Rubino | M | 65 | 2 years | |
| Anne Moore | M | - | - | |
| Adrian Woolfson | M | 60 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | - |
| Philippe Nobels | M | 58 | 7 years | |
| Peggy Sotiropoulou | M | - | 4 years | |
| Elena Spanjaard | M | - | 3 years | |
| David Gilham | M | 59 | 6 years | |
| Alexander M. Milstein | M | 65 | - | |
| Steve Buckanavage | M | - | - | |
| Richard Mountfield | M | - | - | |
| Pierre Brynaert | M | - | - | |
| Philippe Dechamps | M | 54 | 6 years | |
| Warren Sherman | M | - | - | |
| Chris Heymans | M | - | - | |
| Jaak Minten | M | - | - | |
| Charles Q. Morris | M | 59 | 2 years | |
| Carri Duncan | M | - | - | |
| Danny F. Wong | M | 61 | - | |
| Gaëtane Metz | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Belgium | 44 | 74.58% |
| Switzerland | 13 | 22.03% |
| Italy | 10 | 16.95% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marina Udier
- Personal Network
